Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377)
10/2002
10/15/2002US6465444 Protein tyrosine phosphatases(ptp-1b); antidiabetic, antitumor and anorexigenic agents; combination therapy
10/10/2002WO2002079271A2 Acid macromonomers and their method of preparation
10/10/2002WO2002079212A1 Phosphonium phosphinate compounds and their preparation
10/10/2002WO2002079207A2 Tri-and bidentate amido ligands prepared by palladium0 coupling and metallation thereof to form metal-amido catalysts
10/10/2002WO2002079126A1 Cross-metathesis reaction of functionalized and substituted olefins using group 8 transition metal carbene complexes as metathesis catalysts
10/10/2002WO2002079105A1 Corrosion inhibitors for aqueous systems
10/10/2002WO2002078448A1 Insecticide and method of controlling insects
10/10/2002WO2002041827A3 Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis
10/10/2002WO2002027063A3 Vapor deposition of oxides, silicates and phosphates
10/10/2002US20020147354 Squarylium dyes; labeling biological compounds
10/10/2002US20020147288 High molecular weight; isotactic
10/10/2002US20020147234 Nitrate esters and methods of making same
10/10/2002US20020146730 Hydrogel-based microarray signal amplification methods and devices therefor
10/10/2002DE10215356A1 Preparation of olefin 1-hydro-2-carbo addition products, useful e.g. in hydroformylation, by reaction in presence of metal catalyst that includes phosphirane ligand
10/10/2002CA2442368A1 Cross-metathesis reaction of functionalized and substituted olefins using group 8 transition metal carbene complexes as metathesis catalysts
10/09/2002EP1247813A2 Trialkyl group va metal compounds
10/09/2002EP1247803A2 Indolinone compounds suitable for modulation of protein kinases
10/09/2002EP1246830A1 Macrocyclic chelants for metallopharmaceuticals
10/09/2002EP1246829A1 Novel heterocycles
10/09/2002EP1246625A2 Methods and compositions for mitigating pain using nitrate esters
10/09/2002EP1012152B1 Method for preparing oxazaphosphorin-2-amines
10/09/2002EP0958279A4 Catalyst compositions and processes for olefin polymers and copolymers
10/09/2002EP0938379B1 Catalyst and process for the production of aldehydes by hydroformylation of olefinically unsaturated compounds
10/09/2002CN1373766A Phosphonic acid derivs, having carboxypeptidase B inhibitory activity
10/09/2002CN1373765A Calcium complex of phosphorus contg. ethylenediamine derivs.
10/09/2002CN1373745A 3-amino-2-benzyl-1-phenyl-propane derivs.
10/09/2002CN1373133A Fluoro-alpha, omega-di [(fluoro alkyl) fluoro phosphorane] alkane and process for preparing same
10/09/2002CN1092202C Substd. aminoalkane phosphonic acids
10/09/2002CN1092201C Alkylphenylbisacylphosphine oxides and photo initiator mixtures
10/08/2002US6462216 When the reaction product of a phosphorus oxyhalide and an aromatic hydroxy compound in presence of lewis acid catalyst is purified by distillation in the presence of an alkali metal salt, the disproportionation reaction is supressed
10/08/2002US6462200 Diphosphines
10/08/2002US6462194 2,4-disubstituted pyrrolidine-3-carboxylic acid derivatives
10/08/2002US6462184 Compounds, processes and intermediates for synthesis of mixed backbone oligomeric compounds
10/08/2002US6461876 Chemiluminescent 1,2-dioxetanes
10/08/2002CA2108160C Chiral tridentate bis(phospholane) ligands
10/08/2002CA2066083C Benzodiazepine analogs as cholecystokinin antagonists
10/08/2002CA2063852C Asymmetric aryl phosphites
10/07/2002WO2001076598A1 Stabilized pharmaceutical compositions containing calcium channel blockers
10/03/2002WO2002076999A1 Catalysts characterized by a donor-acceptor interaction
10/03/2002WO2002076997A1 Method for producing non-chiral organic compounds containing optically active hydroxy groups
10/03/2002WO2002076996A1 Method for producing diphosphines and the use thereof
10/03/2002WO2002076995A2 2-amino-propanol derivatives
10/03/2002WO2002076968A1 Malonates as inhibitors of the ice/ced-6 family of cysteine proteases
10/03/2002WO2002076924A1 Ionic liquid, electrolyte salt for storage device, electrolytic solution for storage device, electric double layer capacitor, and secondary battery
10/03/2002WO2002076404A2 Fatty alcohol drug conjugates
10/03/2002WO2002076402A2 Fatty amine drug conjugates
10/03/2002WO2002062157A3 Methods for treating phosphatide-containing mixtures
10/03/2002WO2000040526A3 METHOD FOR PREPARING β-PHOSPHOROUS NITROXIDE RADICALS
10/03/2002WO2000014055A3 Method for producing cyanovaleric acid or esters thereof
10/03/2002US20020143214 Synthesis of non-C2-symmetric bisphosphine ligands as catalysts for asymmetric hydrogenation
10/03/2002US20020143200 Dissolving NbCl5 (niobium chloride) or TaCl5(tantalum chloride) in an alcohol containing ammonia; reacting in low temperature to form niobium(V) alkoxide or the tantalum(V) alkoxide
10/03/2002US20020143184 In crop protection and in the protection of materials
10/03/2002US20020143025 For preventing free radical-mediated cellular damage or disruption; as oxidation inhibitors as additives to fuels, lubricants, rubber, polymers, chemicals, solvents and foodstuffs
10/03/2002US20020142995 To enhance the ability of mammalian red blood cells to deliver oxygen, by delivering ligand for the allosteric site of hemoglobin to the cytoplasm of the red blood cells
10/03/2002US20020142994 Bisphosphonate conjugates and methods of making and using the same
10/03/2002US20020142912 Substituted pyridyl amine complexes, and catalysts
10/03/2002EP1144346A3 Method for preparing beta-phosphorous nitroxide radicals
10/03/2002CA2442178A1 2-amino-propanol derivatives
10/03/2002CA2442165A1 Method for producing non-chiral organic compounds containing optically active hydroxy groups
10/03/2002CA2441337A1 Catalysts characterized by a donor-acceptor interaction
10/02/2002EP1245551A1 1,2-bis(methyl(1,1,3,3-tetramethylbutyl)-phosphino)ethane, process for the preparation thereof, transition metal complexes containing the same as the ligand and uses thereof
10/02/2002EP1244749A2 Mobility-modifying cyanine dyes
10/02/2002EP1244679A1 Purine derivatives
10/02/2002EP1244678A1 Phosphonic acid derivatives as inhibitors of protein tyrosine phosphatase 1b (ptp-1b)
10/02/2002EP1244677A1 Phosphonic acid biaryl derivatives as inhibitors of protein tyrosine phosphatase 1b (ptp-1b)
10/02/2002EP1244641A1 Thiazolyl amide derivatives
10/02/2002EP1173450B1 Method for producing sulfonated aryl phosphines
10/02/2002EP1151034A4 Phosphite additives in polyolefins
10/02/2002EP1000021B1 Hydrocyanation of diolefins and isomerization of nonconjugated 2-alykl-3-monoalkenenitriles
10/02/2002EP0960107B1 6-thio-substituted paclitaxels
10/02/2002EP0882730B1 Phosphonic acid diester derivatives
10/02/2002EP0842181B1 Membrane-permeant second messengers
10/02/2002EP0836634B1 Regenerated cellulose incorporating phosphorous compounds so as to be flame-retardant
10/02/2002EP0715628B1 Substituted azaindolylidene compounds and process for their preparation
10/02/2002DE19938622C2 Verfahren zur Herstellung von N-(Phosphonomethyl)glycin Process for the preparation of N- (phosphonomethyl) glycine
10/02/2002DE10119278C1 Preparation of (per)fluoroalkylperfluorophosphates, used as conductive salt in battery, capacitor, supercapacitor or galvanic cell, involves reacting fluoroalkylphosphorane with metal or nonmetal fluoride without solvent
10/02/2002CN1372562A Imidazoimidazoles and triazoles as anti-inflammatory agents
10/02/2002CN1372549A Fungicidies
10/02/2002CN1372543A new vitamin derivatives with cyclic substructures in the side chains, method and intermediates for their production and their use in the preparation of medicaments
10/02/2002CN1371911A Fluoalkyl phosphate and preparation process thereof
10/02/2002CN1091772C Formation of 1-phenylvinyl-1-phosphonic acid
10/02/2002CN1091768C Novel benzo-1,3-dioxolyl-and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists
10/02/2002CN1091649C Process for preparing carboxylic acid salts and catalysts useful in such process
10/02/2002CN1091601C Use of phenol substituted diphosphonates as antineoplastic agents
10/02/2002CN1091594C Use of anti-viral compound in preparing medicine for curing virus infection
10/01/2002US6459003 Ether compounds
10/01/2002US6458998 Naphthaleneureas as antidiabetic agents
10/01/2002US6458986 Intermediate for (R)-3-(4-Bromobenzyl)-1-(3,5-dichlorophenyl)-5-iodo-3-methyl-1-H-imidazo[1,2-α]imidazol-2-one
10/01/2002US6458978 Fluorous phosphines and process for their preparation
10/01/2002US6458961 Water soluble prodrugs of azole compounds
10/01/2002US6458872 Benzotriazole UV absorbers having enhanced durability
10/01/2002US6458868 Organophosphorus compounds for dental polymerizable compositions
10/01/2002US6458854 Administering to the mammal in the need of dry eye treatment a phospholipid-hydrkoxyeicosatetraenoic acid derivative
10/01/2002US6458853 Treating dry eye
10/01/2002US6458829 Substituted γ-phenyl-Δ-lactones and analogs thereof and uses related thereto
10/01/2002US6458816 Anticancer agents
10/01/2002US6458772 Prodrugs
10/01/2002US6458292 Composition of an anti-scale-forming agent
10/01/2002CA2065104C Erucyl, brassidyl and nervonyl derivatives
09/2002
09/30/2002CA2343456A1 Novel phosphonium phosphinate compounds and their methods of preparation